Breaking News Instant updates and real-time market news.

APD

Air Products

$133.95

1.67 (1.26%)

, CC

Chemours

$16.01

0.75 (4.91%)

14:01
10/18/16
10/18
14:01
10/18/16
14:01

Air Products signs pact for supply of industrial gases to Chemours

Air Products (APD) announced the signing of an agreement for the supply of multiple industrial gases to Chemours Company FC (CC). Air Products will build, own and operate an air separation unit in New Johnsonville, Tennessee to produce oxygen, nitrogen, and argon, and will also supply Chemours with compressed dry air and breathing air for its established titanium dioxide production facility. The new Air Products plant is to be onstream in the fall of 2018.

APD

Air Products

$133.95

1.67 (1.26%)

CC

Chemours

$16.01

0.75 (4.91%)

  • 27

    Oct

  • 07

    Nov

APD Air Products
$133.95

1.67 (1.26%)

08/12/16
08/12/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: Alibaba (BABA) upgraded to Strong Buy from Outperform at Raymond James, to Outperform from Neutral at Macquarie, and to Conviction Buy from Buy at Goldman. 2. Foot Locker (FL) upgraded to Buy from Neutral at B. Riley with analyst Mitchel Kummetz citing continued strength in athletic footwear. 3. NVIDIA (NVDA) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mitch Stevens saying the company reported " blow out" results, as its data center business beat expectations by a significant amount. 4. BlackBerry (BBRY) upgraded to Outperform from Market Perform at Raymond James with analyst Steven Li saying BlackBerry's narrative is shifting towards software and sees 80% recurring revenues, 15% organic growth, and 30% Earnings Before Interest Tax Depreciation and Amortization margins. Given the profit growth and profitability profile of software, Li raised BlackBerry's price target to $10.50 from $8. 5. Air Products (APD) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the company is likely to have a "far stronger" capital structure following the close of the sale of its Performance Materials business and the spin of Versum Materials to its shareholders. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/16
OPCO
09/19/16
INITIATION
Target $28
OPCO
Outperform
Versum Materials initiated with an Outperform at Oppenheimer
Oppenheimer analyst Ian Zaffino initiated Versum Materials (VSM) with an Outperform rating and $28 target, saying the stock will offer a play on the proliferation of consumer devices, increasingly complex semiconductor design and an industry that has become less cyclical when the separation from Air Products (APD) is completed. Air Products previously said it expects "regular way" trading of Versum common stock to begin on the NYSE on October 3.
09/23/16
JEFF
09/23/16
INITIATION
Target $26
JEFF
Hold
Versum Materials initiated with a Hold at Jefferies
Jefferies analyst Laurence Alexander started then when issued shares of Versum Materials (VSM) with a Hold rating and $26 price target. The company is being spun off from Air Products (APD).
09/30/16
ATLE
09/30/16
UPGRADE
ATLE
Neutral
Air Products upgraded to Neutral from Underweight at Atlantic Equities
CC Chemours
$16.01

0.75 (4.91%)

03/14/16
GSCO
03/14/16
UPGRADE
Target $10
GSCO
Buy
Chemours upgraded to Buy from Neutral at Goldman
Goldman analyst Robert Koort Chemours to Buy and raised his price target to $10 from $6. The analyst upgraded shares based on valuation, signs that the TiO2 market is bottoming, progress on PFOA, and cost cutting and asset monetization efforts that should help drive 2016 earnings momentum.
07/06/16
SUSQ
07/06/16
NO CHANGE
SUSQ
Jury ruling a significant setback for Chemours, says Susquehanna
After a jury found that DuPont (DD) is liable in a case evaluating whether drinking water tainted with C8, a chemical used in the manufacturing of Teflon, caused a plaintiff's testicular cancer, Susquehanna called the ruling a significant setback for Chemours (CC). The jury not only awarded compensatory damages, but also determined that punitive damages are warranted, noted the firm, which pointed out that Chemours is the real party at risk, as it must indemnify DuPont for all of these PFOA litigation damages, with this trial representing only the third of 3,512 personal injury and 30 wrongful death cases facing the companies. Chemours shares are near their session lows, down about 19% in late afternoon trading following news of the jury ruling.
08/10/16
ARGS
08/10/16
UPGRADE
ARGS
Buy
Chemours upgraded to Buy from Hold at Argus
08/10/16
ARGS
08/10/16
UPGRADE
ARGS
Buy
Chemours upgraded on competitive advantages, valuation at Argus
As noted earlier, Argus upgraded Chemours to Buy from Hold. Analyst David Coleman believes that the company "has significant competitive advantages," while its valuation is "favorable." Target $13.

TODAY'S FREE FLY STORIES

16:31
04/25/17
04/25
16:31
04/25/17
16:31
Options
Preliminary option volume of 19.4M today »

Preliminary option volume…

TXN

Texas Instruments

$82.37

1.29 (1.59%)

16:30
04/25/17
04/25
16:30
04/25/17
16:30
Earnings
Texas Instruments reports Q1 EPS 97c, consensus 83c »

Reports Q1 revenue $3.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 31

    May

CHSP

Chesapeake Lodging

$24.70

0.29 (1.19%)

16:29
04/25/17
04/25
16:29
04/25/17
16:29
Earnings
Chesapeake Lodging sees Q2 AFFO 60c-64c »

Sees Q2 EPS 27c-30c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 17

    May

TGI

Triumph Group

$26.20

-0.05 (-0.19%)

16:29
04/25/17
04/25
16:29
04/25/17
16:29
Hot Stocks
Triumph Group, VAS Aero collaborate on PW4168 Nacelles »

Triumph Group said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNPR

Juniper

$27.78

-0.49 (-1.73%)

16:28
04/25/17
04/25
16:28
04/25/17
16:28
Earnings
Juniper reports preliminary Q1 EPS 46c, consensus 42c »

Reports preliminary Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    May

  • 08

    Jun

CHSP

Chesapeake Lodging

$24.70

0.29 (1.19%)

16:28
04/25/17
04/25
16:28
04/25/17
16:28
Earnings
Chesapeake Lodging backs FY17 adjusted FFO $2.10-$2.20 »

Backs FY17 EPS 73c-83c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 17

    May

ARCW

ARC Group

$3.85

0.05 (1.32%)

16:28
04/25/17
04/25
16:28
04/25/17
16:28
Hot Stocks
Breaking Hot Stocks news story on ARC Group »

Northern Right Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHSP

Chesapeake Lodging

$24.70

0.29 (1.19%)

16:27
04/25/17
04/25
16:27
04/25/17
16:27
Earnings
Chesapeake Lodging reports Q1 adjusted FFO 41c »

Reports Q1 EPS 9c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 17

    May

BXMT

Blackstone Mortgage

$30.91

0.28 (0.91%)

16:26
04/25/17
04/25
16:26
04/25/17
16:26
Earnings
Blackstone Mortgage reports Q1 core EPS 61c, consensus 63c »

Reports book value of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCUR

Concurrent

$4.94

0.0626 (1.28%)

16:26
04/25/17
04/25
16:26
04/25/17
16:26
Hot Stocks
Concurrent announces availability of Origin Release 3 »

Concurrent announces the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHS

Universal Health

$121.42

0.52 (0.43%)

16:25
04/25/17
04/25
16:25
04/25/17
16:25
Earnings
Universal Health reports Q1 adjusted EPS $2.10, consensus $2.07 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

PCG

PG&E

$67.66

-0.13 (-0.19%)

, EIX

Edison International

$80.82

-0.12 (-0.15%)

16:25
04/25/17
04/25
16:25
04/25/17
16:25
Hot Stocks
PG&E, CA energy companies propose reforms to CPUC »

PG&E (PCG) joined…

PCG

PG&E

$67.66

-0.13 (-0.19%)

EIX

Edison International

$80.82

-0.12 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 01

    May

  • 02

    May

DECK

Deckers Brands

$58.74

0.4 (0.69%)

16:25
04/25/17
04/25
16:25
04/25/17
16:25
Technical Analysis
Deckers Brands spikes after saying it will review strategic alternatives »

The stock was last at $62…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVXS

AveXis

$78.74

-0.44 (-0.56%)

16:25
04/25/17
04/25
16:25
04/25/17
16:25
Conference/Events
AveXis to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    Jun

TRN

Trinity Industries

16:24
04/25/17
04/25
16:24
04/25/17
16:24
Earnings
Trinity Industries sees 2017 EPS $1.00-$1.25 vs. prior outlook $1.00-$1.35 

Consensus $1.23.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 01

    May

  • 09

    May

CHFC

Chemical Financial

$50.36

-0.35 (-0.69%)

16:24
04/25/17
04/25
16:24
04/25/17
16:24
Earnings
Chemical Financial reports Q1 EPS 71c, consensus 70c »

Net interest income was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 03

    May

WK

Workiva

$16.80

-0.05 (-0.30%)

16:24
04/25/17
04/25
16:24
04/25/17
16:24
Hot Stocks
Workiva partners with Fastpath »

Workiva and Fastpath,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

UVE

Universal Insurance

$23.35

0.45 (1.97%)

16:24
04/25/17
04/25
16:24
04/25/17
16:24
Earnings
Universal Insurance reports Q1 EPS 86c, consensus 80c »

Book value per common was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CCI

Crown Castle

$94.27

-0.44 (-0.46%)

16:23
04/25/17
04/25
16:23
04/25/17
16:23
Syndicate
Crown Castle 4.75M share Spot Secondary; price range $93.57-$94.27 »

Barclays, RBC Capital,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 18

    May

TRN

Trinity Industries

16:23
04/25/17
04/25
16:23
04/25/17
16:23
Earnings
Trinity Industries reports Q1 EPS 30c, consensus 30c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 01

    May

  • 09

    May

SPN

Superior Energy

$13.47

0.47 (3.62%)

16:23
04/25/17
04/25
16:23
04/25/17
16:23
Earnings
Superior Energy reports Q1 EPS (59c), consensus (61c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 01

    May

  • 01

    May

  • 23

    May

ZIXI

ZixCorp

$5.21

-0.14 (-2.62%)

16:23
04/25/17
04/25
16:23
04/25/17
16:23
Earnings
ZixCorp backs FY17 adjusted EPS view of 28c, consensus 27c »

Raises FY17 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 02

    May

  • 03

    May

EW

Edwards Lifesciences

$98.92

0.96 (0.98%)

16:23
04/25/17
04/25
16:23
04/25/17
16:23
Technical Analysis
Edwards Lifesciences spikes higher after results »

In the extended session…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CVA

Covanta

$15.10

0.2 (1.34%)

16:23
04/25/17
04/25
16:23
04/25/17
16:23
Hot Stocks
Covanta sees FY17 adjusted EBITDA $400M-$440M »

Sees FY17 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 22

    May

  • 23

    May

DECK

Deckers Brands

$58.74

0.4 (0.69%)

16:22
04/25/17
04/25
16:22
04/25/17
16:22
Hot Stocks
Deckers Brands to review strategic alternatives »

Deckers Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.